2020-06-15T15:06:15-05:00 2019-06-30 366055558 GRANT THORNTON LLP 200 S ORANGE AVENUE SUITE 2050 ORLANDO FL 32801 990 2018-07-01 593238640 H LEE MOFFITT CANCER CENTER & RESEARCH INST LIFETIME CANCER SCREENING CTR INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 YVETTE TREMONTI EVP/CFAO 8137457862 2020-06-15 1 MICHELE N MELCHIOR P00488037 4074815100 206.81.166.225 2020-06-15 16:05:58 ED P D2268DC0E314446CAE51FD37060A099F72BE2B16 AA37F9CC9096A692BA6EB6CD348E4F28C9C00095 2018 2020-04-17 16:48:07Z MOFFITT MEDICAL GROUP G DOUGLAS LETSON 12902 MAGNOLIA DRIVE TAMPA FL 33612 97674225 0 X WWW.MOFFITT.ORG X 1994 FL TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBS. 15 13 809 14 7688543 237397 1728852 1749260 93818247 95922582 0 0 5505 2383 95552604 97674225 0 0 0 0 149629566 175276802 0 0 0 20611774 21980857 170241340 197257659 -74688736 -99583434 9167760 10571913 10627190 11422021 -1459430 -850108 X TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC (CANCER CENTER), H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL (HOSPITAL), AND H. LEE MOFFITT CANCER CONTINUED ON SCHEDULE OFOUNDATION BY EMPLOYING PHYSICIANS WHO STAFF THE HOSPITAL, BY MANAGING THEIR PRACTICE AND BY EMPLOYING THE CLINICAL SCIENTISTS WHO PROVIDE CLINICAL RESEARCH SERVICES. 0 0 175697247 95922582 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") EMPLOYS THE PHYSICIANS (KNOWN AS THE MOFFITT MEDICAL GROUP) THAT STAFF THE HOSPITAL AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER HEALTH CARE SYSTEM. THE PROVISION OF PRACTICE MANAGEMENT SERVICES TO ITS EMPLOYED PHYSICIANS AND CLINICAL SCIENTISTS ENHANCES THE EFFICIENCY OF HEALTHCARE AND RESEARCH SERVICES PROVIDED BY THESE EMPLOYEES. THIS BENEFITS ALL ENTITIES IN THE CANCER CENTER HEALTH CARE SYSTEM AND PROMOTES AND SUPPORTS THE RESEARCH AND ACADEMIC MISSIONS OF THE CANCER CENTER HEALTH CARE SYSTEM. 175697247 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 33 0 1 809 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 15 13 1 0 0 0 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 0 X YVETTE M LYONS TREMONTI 8137457862 12902 MAGNOLIA DR TAMPA FL 33612 X ALLAN MARTIN DIRECTOR, CHAIR 1.00 1.00 X X 0 0 0 FRANK CAPITANO DIRECTOR, VICE CHAIR 1.00 0.00 X X 0 0 0 TIMOTHY J ADAMS DIRECTOR, IMMED PAST CHAIR 1.00 1.00 X X 0 0 0 THE HON H LEE MOFFITT ESQ DIRECTOR, SECRETARY/TREASU 1.00 2.00 X X 0 0 0 JOEDRECKA BROWN SPEIGHTS MD DIRECTOR 1.00 0.00 X 0 0 0 HUGO FERNANDEZ MD DIRECTOR;DEPT CHAIR MAL HEM 51.00 0.00 X 678492 0 -1194 REGINALD GOINS DIRECTOR 1.00 1.00 X 0 0 0 NIKHIL KHUSHALANI DIRECTOR, SR MBR HEMONCMED 51.00 0.00 X 438875 0 37680 MARTHA TRUSLOW LANAHAN DIRECTOR 1.00 0.00 X 0 0 0 MICHAEL O'MALLEY DIRECTOR 1.00 0.00 X 0 0 0 ROBERT J PEREZ DIRECTOR 1.00 0.00 X 0 0 0 THE HON MARK A PIZZO ESQ DIRECTOR 1.00 1.00 X 0 0 0 SHARMILA SETH DIRECTOR AS OF 5/2019 1.00 0.00 X 0 0 0 MARK WATSON DIRECTOR 1.00 0.00 X 0 0 0 VICTOR YOUNG DIRECTOR 1.00 0.00 X 0 0 0 G DOUGLAS LETSON PRES,EVP-PIC 22.00 33.00 X 0 872364 -8011 LOUIS D DE LA PARTE EVP-GENERAL COUNSEL;ASST SEC 8.00 49.00 X 0 685964 -27239 YVETTE M LYONS TREMONTI EVP-CFAO & ASST TREASURER 8.00 49.00 X 0 807960 -2680 SURESH D SERAPHIN VP STRATEGIC ALLIANCE & NETWK 10.00 45.00 X 0 154055 -705 CYNTHIA TERRANO VP PAYER STRATEGIES 20.00 35.00 X 0 412789 66112 KAREN WARTENBERG VP MOFFITT MEDICAL GROUP 55.00 0.00 X 0 269752 18578 JOANNA WEISS VP FINANCE 10.00 45.00 X 0 360898 23359 LOUIS B HARRISON VP CHIEF PARTNERSHIP OFFICER 55.00 0.00 X 951215 0 31247 ROBERT A GATENBY DEPT CHAIR DIAGNOSTIC IMAG 55.00 0.00 X 858224 0 14280 DAVID N THRUSH DEPT CHAIR ANESTHESIOLOGY 55.00 0.00 X 715392 0 -7025 BRIAN CZERNIECKI DEPT CHAIR BREAST ONCOLOGY 50.00 0.00 X 726795 0 52595 JASON B FLEMING DEPT CHAIR GI TUMOR 50.00 0.00 X 769553 0 49788 LARY ROBINSON SR MBR THORCARDIO 50.00 0.00 X 806490 0 -139768 ERIC M TOLOZA SR MBR THORCARDIO 50.00 0.00 X 694459 0 23237 VERNON K SONDAK DEPT CHAIR CUTANEOUS ONC 50.00 0.00 X 690607 0 15173 JULIO M POW-SANG MD FRM DIR 9/2017;DEPT CHAIR GU 50.00 0.00 X 927655 0 9610 BRAULIO VICENTE JR FRM SVP MMG AS OF 11/4/2017 0.00 0.00 X 0 331359 -26180 8257757 3895141 128857 445 1 1 0 CONIFER HEALTH SOLUTIONS 2960 PROFESSIONAL DRIVE SPRINGFIELD IL 62703 BILLING AND COLLECTION SERVICES 3423379 MEDICAL DOCTOR ASSOCIATES LLC 145 TECHNOLOGY PARKWAY NW NORCROSS GA 30092 OUTSOURCED CLINICAL SERVICES 909728 FIRST CLASS MOVING SYSTEMS INC 8110 ANDERSON RD STE 100 TAMPA FL 33634 MOVING SERVICES 130663 3 400610 1348650 1749260 NET PATIENT SERVICE REVENUE 900099 86872485 86872485 MHS MANAGEMENT SERVICES 541610 4413214 4413214 BAYCARE MANAGEMENT SERVICES 541610 3122800 3122800 PHYSICIAN AFFILIATE FEES 900099 794302 794302 SHARED SAVINGS PROGRAM 900099 436404 436404 283377 130848 152529 95922582 INTEREST FROM INS CO 900099 2383 2383 2383 97674225 88234039 7688543 2383 X 3826962 3709682 117280 958893 929507 29386 146636148 134510902 12125246 7889110 7304215 584895 8682710 8078338 604372 7282979 6564000 718979 403639 403639 38967 38967 5918586 3591109 2327477 1100906 41212 1059694 1029290 63924 965366 3437011 3437011 1319011 1319011 479071 397820 81251 242054 242054 1705006 1705006 1631281 1631281 ALLOCATION OF INTERCO E 0 7270164 -7270164 PROFESSIONAL DEVELOPMEN 1568459 1537828 30631 INCOME TAX EXPENSE 1118059 1118059 BAD DEBT EXPENSE 972805 972805 1016712 725741 290971 197257659 175697247 21560412 0 9081267 10482995 8015 8588 105006 59864 10708 45142 67770 35188 9167760 10571913 10627190 11422021 10627190 11422021 X -1459430 -850108 -1459430 -850108 9167760 10571913 -99583434 100192756 X X 0 1 X 1 0 X 375772 669275 680408 1728852 1749260 5203567 75307613 77008612 81144481 93818247 88234039 415512992 75683385 77677887 81824889 95547099 89983299 420716559 0 0 0 420716559 19966 7688543 7708509 12956 5505 2383 20844 75696341 77677887 81844855 95552604 97674225 428445912 0.98200 0.99990 0.00000 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: REFUND - 2014 AMOUNT: $ 12,956. SETTLEMENT - 2017 AMOUNT: $ 5,505. INTEREST FROM INS CO - 2018 AMOUNT: $ 2,383. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 105006 59864 45142 45142 X PART X, LINE 2: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. DID NOT HAVE ANY UNCERTAIN POSITIONS IN ITS AUDITED FINANCIAL STATEMENTS. THE ASC-740 FOOTNOTE READS AS FOLLOWS: THE CANCER CENTER RECOGNIZES A TAX POSITION AFTER DETERMINING THAT A RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT (GREATER THAN 50% LIKELIHOOD) SUSTAIN THE POSITION FOLLOWING AN AUDIT AND RECORDS THESE BENEFITS AT THE AMOUNT MOST LIKELY TO BE REALIZED, ASSUMING A REVIEW BY TAX AUTHORITIES HAVING ALL RELEVANT INFORMATION AND APPLYING CURRENT CONVENTIONS. X 0 0 1 1 0 0 0 1 1 0 0 HUGO FERNANDEZ MD DIRECTOR;DEPT CHAIR MAL HEM 545779 0 109350 0 23363 0 -18080 0 23446 0 683858 0 0 0 NIKHIL KHUSHALANI DIRECTOR, SR MBR HEMONCMED 361172 0 71928 0 5775 0 11896 0 34263 0 485034 0 0 0 G DOUGLAS LETSON PRES,EVP-PIC 0 612169 0 204140 0 56055 0 -24897 0 22793 0 870260 0 0 LOUIS D DE LA PARTE EVP-GENERAL COUNSEL;ASST SEC 0 489889 0 158449 0 37626 0 -45565 0 26381 0 666780 0 0 YVETTE M LYONS TREMONTI EVP-CFAO & ASST TREASURER 0 564298 0 179926 0 63736 0 -29294 0 33406 0 812072 0 0 SURESH D SERAPHIN VP STRATEGIC ALLIANCE & NETWK 0 106482 0 20000 0 27573 0 -979 0 5320 0 158396 0 0 CYNTHIA TERRANO VP PAYER STRATEGIES 0 320558 0 89140 0 3091 0 39430 0 28200 0 480419 0 0 KAREN WARTENBERG VP MOFFITT MEDICAL GROUP 0 210391 0 50343 0 9018 0 -12056 0 38292 0 295988 0 0 JOANNA WEISS VP FINANCE 0 268654 0 75104 0 17140 0 -7653 0 38458 0 391703 0 0 LOUIS B HARRISON VP CHIEF PARTNERSHIP OFFICER 778170 0 164021 0 9024 0 14361 0 25212 0 990788 0 0 0 ROBERT A GATENBY DEPT CHAIR DIAGNOSTIC IMAG 709889 0 137691 0 10644 0 -2606 0 25111 0 880729 0 0 0 DAVID N THRUSH DEPT CHAIR ANESTHESIOLOGY 593046 0 113322 0 9024 0 -17721 0 15697 0 713368 0 0 0 BRIAN CZERNIECKI DEPT CHAIR BREAST ONCOLOGY 589144 0 132749 0 4902 0 16873 0 38914 0 782582 0 0 0 JASON B FLEMING DEPT CHAIR GI TUMOR 699211 0 67720 0 2622 0 24004 0 37402 0 830959 0 0 0 LARY ROBINSON SR MBR THORCARDIO 699512 0 81333 0 25645 0 -148651 0 17749 0 675588 0 0 0 ERIC M TOLOZA SR MBR THORCARDIO 624108 0 65449 0 4902 0 -2547 0 32761 0 724673 0 0 0 VERNON K SONDAK DEPT CHAIR CUTANEOUS ONC 556595 0 124988 0 9024 0 -1255 0 23070 0 712422 0 0 0 JULIO M POW-SANG MD FRM DIR 9/2017;DEPT CHAIR GU 716523 0 201427 0 9705 0 -15471 0 30253 0 942437 0 0 0 BRAULIO VICENTE JR FRM SVP MMG AS OF 11/4/2017 0 0 0 0 0 331359 0 -26180 0 -402 0 304777 0 0 PART I, LINE 1A INCLUDED IN HUGO FERNANDEZ'S COMPENSATION IS A HOUSING STIPEND IN THE AMOUNT OF $18,461 RELATED TO AN AFFILIATION/SERVICE AGREEMENT WITH MEMORIAL HEALTHCARE IN SOUTH FLORIDA. PART I, LINE 1B HOUSING ALLOWANCE WAS TREATED AS A SUPPLEMENTAL WAGE (BONUS) PAYMENT, BASED ON MARKET RENTALS FOR THE GEOGRAPHICAL LOCATION. SUPPLEMENTAL WAGE PAYMENTS ARE NOT BASED ON WRITTEN POLICY. PART I, LINE 3 LCS RELIES ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, A RELATED ORGANIZATION WHICH USES AN INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEYS OR STUDIES, AN EXECUTIVE COMPENSATION COMMITTEE, AND THE APPROVAL BY THE BOARD OR THE EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD, TO ESTABLISH THE PHYSICIAN IN CHIEF/PRESIDENT'S AND TOP MANAGEMENT OFFICIALS' COMPENSATION. PART I, LINES 4A-B BRAULIO VICENTE,OFFICER, RECEIVED SEVERANCE PAYMENTS FROM A RELATED ORGANIZATION, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC., IN THE AMOUNT OF $294,566. TO BE ELIGIBLE TO PARTICIPATE IN THE 457(F) NON-QUALIFIED SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP), PARTICIPANTS MUST ELECT TO CONTRIBUTE AT LEAST 10% ACROSS THE 403(B) AND 457(B) PLANS, AND ARE VESTED AFTER 10 YEARS OF SERVICE. LUMP SUM DISTRIBUTIONS FROM THE ACCOUNT ARE MADE UPON NORMAL RETIREMENT OR TERMINATION. BELOW ARE INDIVIDUALS LISTED ON LCS'S 2018 FORM 990 PART VII, SECTION A, THAT PARTICIPATED IN THE 457(F) SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND THEIR RESPECTIVE AMOUNTS OF COMPENSATION CONSTRUCTIVELY RECEIVED IN TAX YEAR 2018 FROM THE PLAN: BRAULIO VICENTE-$36,793 LOUIS D. DE LA PARTE-$32,925 G. DOUGLAS LETSON-$51,153 YVETTE M. LYONS TREMONTI-$41,914 ROBERTY A. GATENBY-$,1,500 CYNTHIA TERRANO-$0 DAVID N. THRUSH-$1,500 BRIAN CZERNIECKI-$0 LARY ROBINSON-$1,500 VERNON K. SONDAK-$1,500 KAREN WARTENBERG-$0 JOANNA WEISS-$5,120 JULIO M. POW-SANG-$2,181 LOUIS B. HARRISON-$1,500 NIKHIL KHUSHALANI-$4560 PART I, LINE 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON MOFFITT'S ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS RELATED TO NET OPERATING INCOME AND ON DIVISION OR INDIVIDUAL GOALS. NET OPERATING INCOME MUST MEET OR EXCEED A CERTAIN THRESHOLD IN ORDER TO TRIGGER A PAYOUT FOR THE ORGANIZATIONAL GOAL COMPONENTS. PART I, LINE 2: SUBSTANTIATION IS NOT REQUIRED FOR PAYMENTS CLASSIFIED AS A SUPPLEMENTAL WAGE WHERE TAXES ARE WITHHELD AT THE SUPPLEMENTAL RATE. SCHEDULE J COLUMN C: ANNUAL DECREASES IN ACTURIAL VALUE OF THE DEFINED BENEFIT PLAN IS INCLUDED IN RETIREMENT AND OTHER DEFERRED COMPENSATION. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. LCS & MOFFITT TECHNOLOGIES CORPORATION: YVETTE LYONS TREMONTI, OFFICER LOUIS D. DE LA PARTE, OFFICER LCS & M2GEN, CORP.: ALLAN MARTIN, DIRECTOR LOUIS D. DE LA PARTE, OFFICER YVETTE LYONS TREMONTI, OFFICER TWO DIRECTORS HAVE A BUSINESS RELATIONSHIP WITH A VENDOR OF LCS'S RELATED ORGANIZATION, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. TIMOTHY J. ADAMS IS AN INVESTOR AND OWNS EQUITY IN LUMINA ANALYTICS, WHERE ALLAN S. MARTIN IS CHIEF EXECUTIVE OFFICER. FORM 990, PART VI, SECTION A, LINE 6 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS THE SOLE MEMBER OF LCS. FORM 990, PART VI, SECTION A, LINE 7A AS THE SOLE MEMBER OF LCS, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. SHALL HAVE THE POWER TO APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF LCS. FORM 990, PART VI, SECTION A, LINE 7B H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (AS SOLE MEMBER) SHALL ALSO HAVE THE FOLLOWING POWERS: A. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE ARTICLES OF INCORPORATION OF THE CORPORATION; B. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE BYLAWS OF THE CORPORATION; C. APPROVE, DISAPPROVE OR RECOMMEND THE SELECTION OF A QUALIFIED AUDIT FIRM AND THE ANNUAL OPERATING AND CAPITAL BUDGETS OF THE CORPORATION; D. EITHER APPROVE OR DISAPPROVE THE TRANSFER, SALE, LEASE OR DISPOSITION OF ANY ASSET OF THE CORPORATION IN EXCESS OF TWO HUNDRED THOUSAND DOLLARS ($200,000.00); E. APPROVE OR DISAPPROVE THE CONFERRING OF ANY LIEN OR SECURITY INTEREST IN ASSETS OF THE CORPORATION IN EXCESS OF ONE MILLION DOLLARS ($1,000,000.00), WHETHER SAME SHALL BE IN CONNECTION WITH EITHER PUBLIC OR PRIVATE FINANCING, OR OTHERWISE; F. APPROVE OR DISAPPROVE ALL DONATIONS OR CHARITABLE CONTRIBUTIONS BY THE CORPORATION IN EXCESS OF TWENTY THOUSAND DOLLARS ($20,000.00) PER CONTRIBUTION OR ANNUAL CONTRIBUTION EXCEEDING FIFTY THOUSAND DOLLARS ($50,000.00) IN THE AGGREGATE; G. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION OF THE CORPORATION'S MISSION AND PHILOSOPHY STATEMENT; AND H. APPROVE OR DISAPPROVE CAPITAL EXPENDITURES BY THE CORPORATION IN EXCESS OF ONE MILLION DOLLARS ($1,000,000.00) PER EXPENDITURE OR ONE MILLION DOLLARS ($1,000,000.00) IN THE AGGREGATE ANNUALLY. I. APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF THE CORPORATION. FORM 990, PART VI, SECTION A, LINE 8B LCS DOES NOT HAVE A COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B LINE 11B, PRIOR TO ELECTRONICALLY FILING FORM 990 (RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX), A COPY OF THE RETURN IS PROVIDED TO THE GOVERNING BODY, GIVING EACH BOARD MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. THE LCS'S FORM 990 IS ALSO PROVIDED TO THE CHIEF FINANCIAL OFFICER FOR REVIEW. BASED ON THE REVIEW ANY SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED PRIOR TO SIGNING. FORM 990, PART VI, SECTION B, LINE 12C ON AN ANNUAL BASIS A PRESENTATION IS MADE TO LCS BOARD MEMBERS TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM ATTACHED TO THE POLICY. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS/HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS OF H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. ("MOFFITT"), A RELATED ENTITY, HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE DIRECTORS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE PERFORMANCE AND COMPENSATION OF MOFFITT AND ITS SUBSIDIARIES' EXECUTIVES AND DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS AND DEPARTMENT CHAIRPERSONS. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN AS NEEDED AND DOES AT ITS DISCRETION, ENGAGE OUTSIDE INDEPENDENT, OUTSIDE ADVISORS INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH EXECUTIVE, DISQUALIFIED PERSON AND INDIVIDUAL IN KEY POSITIONS. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED POSITION TO ITS APPROPRIATE MARKET EQUIVALENT. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE EXECUTIVE OR DISQUALIFIED PERSON CATEGORIES, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS ALONG WITH THE CONSULTANT'S COMPARABILITY DATA ARE PRESENTED TO THE JEC&BC FOR IT TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. EVERY THIRD YEAR THE INDEPENDENT CONSULTANT ANALYZES THE TOTAL EXECUTIVE COMPENSATION PROGRAM, USING THE SAME METHODOLOGY AS DESCRIBED ABOVE, THAT INCLUDES THE VALUE OF ALL BENEFITS AND PERQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE EXECUTIVES AND DISQUALIFIED PERSONS. THE PURPOSE OF THE ANALYSIS IS TO PROVIDE AN OPINION ON THE REASONABLENESS OF EACH OF THE INDIVIDUAL COMPENSATION COMPONENTS AND THE AGGREGATE COMPENSATION TOTAL. THIS MORE COMPREHENSIVE ANALYSIS IS PROVIDED TO THE JEC&BC FOR THEIR USE IN THE ANNUAL REVIEW PROCESS. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE FULL BOARD. FORM 990, PART VI, SECTION C, LINE 19 LCS MAKES AVAILABLE ITS CONSOLIDATED AUDITED FINANCIAL STATEMENTS TO THE PUBLIC THROUGH DACBOND, A THIRD PARTY VENDORS' WEBSITES. IN ADDITION, FORM 990 IS MADE AVAILABLE ON GUIDESTAR AS WELL AS MOFFITT'S WEBSITE. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1A: EMPLOYEES WHO ARE LISTED ON MOFFITT LCS'S FORM 990 ARE EMPLOYEES WHOSE W-2'S WERE ISSUED BY MOFFITT INSTITUTE, THE COMMON PAYMASTER AND RELATED ENTITY. PROCEDURES TO REPORT COMPENSATION OF EMPLOYEES ON FORM 990 PART VII AND ON SCHEDULE J ARE IN ACCORDANCE WITH IRS INSTRUCTIONS FOR EACH RESPECTIVE SECTION. FORM 990, PART VII, SECTION A, COL F: ANNUAL DECREASE IN ACTURIAL VALUE OF DEFINED BENEFIT PLAN ARE INCLUDED IN OTHER COMPENSATION. FORM 990, PART IX, COLUMN (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE THE CONTRIBUTIONS ARE FROM RELATED ORGANIZATIONS AND OTHER GRANTS. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBSIDIARIES. FORM 990, PART IX, LINE 24A: CERTAIN MOFFITT CANCER CENTER'S INTERCOMPANY OVERHEAD HAS BEEN ALLOCATED FROM THE PARENT (INSTITUTE) ENTITY TO LCS AND THOSE AMOUNTS ARE INCLUDED IN COLUMN (C) AND THEN REALLOCATED ON LINE 24A TO THE PROPER FUNCTIONAL EXPENSE CATEGORIES. FORM 990, PART XI, LINE 9: OTHER CHANGES IN NET ASSETS RELATES TO THE CLOSE OUT OF INTERCOMPANY ACCOUNTS PAYABLE AND RECEIVABLE (DUE TO/DUE FROM) IN THE AMOUNT OF $100,193,398 AND $-642 IN GRANT REFUND RECLASS. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(C)(3) LINE 3 H LEE MOFFITT CANCER CTR & RES INST INC 0 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 PARENT-RESEARCH FL 501(C)(3) LINE 7 N/A 0 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(C)(3) LINE 7 H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL H LEE MOFFITT CANCER CTR & RES INST INC C 0 M2GEN CORP 10902 N MCKINLEY DRIVE TAMPA FL 33612 208486180 DATABASE MANAGEMENT FL H LEE MOFFITT CANCER CTR & RES INST INC C 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0